Time course of synergistic interaction between DOCA and salt on blood pressure: Roles of vasopressin and hepatic osmoreceptors

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 291, Issue 6, 2006, Pages

  Brooks, Virginia L ^a   Freeman, Korrina L ^a   Qi, Yue ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Heart rate; Hypertension; Hypertonic saline; Osmolality; Rats; Telemetry

Indexed keywords

DEOXYCORTICOSTERONE ACETATE; VASOPRESSIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE MONITORING; CARDIOVASCULAR RESPONSE; CONTROLLED STUDY; FLUID RETENTION; HYPERTENSION; MALE; NONHUMAN; OSMOLALITY; OSMORECEPTOR; PRIORITY JOURNAL; RAT; SALT INTAKE;

ANIMALS; BLOOD PRESSURE; DESOXYCORTICOSTERONE; DRUG INTERACTIONS; LIVER; MALE; MECHANORECEPTORS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, VASOPRESSIN; SODIUM CHLORIDE, DIETARY; VASOPRESSINS; WATER-ELECTROLYTE BALANCE;

EID: 33845459740     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00068.2006     Document Type: Article

References (60)

1. Baertschi AJ and Vallet PG. Osmosensitivity of the hepatic portal vein area and vasopressin release in rats. J Physiol 315: 217-230, 1981.
2. Barrett CJ, Guild SJ, Ramchandra R, and Malpas SC. Baroreceptor denervation prevents sympathoinhibition during angiotensin II-induced hypertension. Hypertension 46: 168-172, 2005.
3. Bie P, Wamberg S, and Kjolby M. Volume natriuresis vs. pressure natriuresis. Acta Physiol Scand 181: 495-503, 2004.
4. Brooks VL, Haywood JR, and Johnson AK. Translation of salt retention to central activation of the sympathetic nervous system in hypertension. Clin Exp Pharmacol Physiol 32: 426-432, 2005.
5. Brooks VL and Osborn JW. Hormonal-sympathetic interactions in long-term regulation of arterial pressure: an hypothesis. Am J Physiol Regul Integr Comp Physiol 268: R1343-R1358, 1995.
6. Brooks VL, Qi Y, and O'Donaughy TL. Increased osmolality of conscious water-deprived rats supports arterial pressure and sympathetic activity via a brain action. Am J Physiol Regul Integr Comp Physiol 288: R1248-R1255, 2005.
7. Brooks VL, Scrogin KE, and McKeogh DF. The interaction of angiotensin II and osmolality in the generation of sympathetic tone during changes in dietary salt intake: an hypothesis. Ann NY Acad Sci 940: 380-394, 2001.
8. Brown CM, Barberini L, Dulloo AG, and Montani JP. Cardiovascular responses to water drinking: does osmolality play a role? Am J Physiol Regul Integr Comp Physiol 289: R1687-R1692, 2005.
9. Carlson SH, Beitz A, and Osborn JW. Intragastric hypertonic saline increases vasopressin and central Fos immunoreactivity in conscious rats. Am J Physiol Regul Integr Comp Physiol 272: R750-R758, 1997.
10. Carlson SH, Roysomutti S, Peng N, and Wyss JM. The role of the central nervous system in NaCl-sensitive hypertension in spontaneously hypertensive rats. Am J Hypertens 14: 155S-162S, 2001.
11. Coote JH. A role for the paraventricular nucleus of the hypothalamus in the autonomic control of heart and kidney. Exp Physiol 90: 169-173, 2005.
12. D'Almeida MS, Cailmail S, and Lebrec D. Validation of transit-time ultrasound flow probes to directly measure portal blood flow in conscious rats. Am J Physiol Heart Circ Physiol 271: H2701-H2709, 1996.
13. De Champlain J, Bouvier M, and Drolet G. Abnormal regulation of the sympathoadrenal system in deoxycorticosterone acetate-salt hypertensive rats. Can J Physiol Pharmacol 65: 1605-1614, 1987.
14. De Wardener HE, He FJ, and MacGregor GA. Plasma sodium and hypertension. Kidney Int 66: 2454-2466, 2004.
15. Fang Z, Carlson SH, Peng N, and Wyss JM. Circadian rhythm of plasma sodium is disrupted in spontaneously hypertensive rats fed a high-NaCl diet. Am J Physiol Regul Integr Comp Physiol 278: R1490-R1495, 2000.
16. Ferrario CM, Mohara O, Ueno Y, and Brosnihan KB. Hemodynamic and neurohormonal changes in the development of DOC hypertension in the dog. Am J Med Sci 295: 352-359, 1988.
17. Garcia-Estan J, Carbonell LF, Garcia-Salom M, Salazar FJ, and Quesada T. Hemodynamic effects of hypertonic saline in the conscious rat. Life Sci 44: 1343-1350, 1989.
18. Gomez-Sanchez EP. Central hypertensive effects of aldosterone. Front Neuroendocrinol 18: 440-462, 1997.
19. Habecker BA, Grygielko ET, Huhtala TA, Foote B, and Brooks VL. Ganglionic tyrosine hydroxylase and norepinephrine transporter are decreased by increased sodium chloride in vivo and in vitro. Auton Neurosci 107: 85-98, 2003.
20. He FJ, Markandu ND, Sagnella GA, De Wardener HE, and MacGregor GA. Plasma sodium: ignored and underestimated. Hypertension 45: 98-102, 2005.
21. Huang BS, Van Vliet BN, and Leenen FH. Increases in CSF [Na+] precede the increases in blood pressure in Dahl S rats and SHR on a high-salt diet. Am J Physiol Heart Circ Physiol 287: H1160-H1166, 2004.
22. Huang BS, Wang H, and Leenen FH. Chronic central infusion of aldosterone leads to sympathetic hyperreactivity and hypertension in Dahl S but not Dahl R rats. Am J Physiol Heart Circ Physiol 288: H517-H524, 2005.
23. Jacob F, Clark LA, Guzman PA, and Osborn JW. Role of renal nerves in development of hypertension in DOCA-salt model in rats: a telemetric approach. Am J Physiol Heart Circ Physiol 289: H1519-H1529, 2005.
24. Jordan J, Shannon JR, Black BK, Ali Y, Farley M, Costa F, Diedrich A, Robertson RM, Biaggioni I, and Robertson D. The pressor response to water drinking in humans: a sympathetic reflex? Circ 101: 504-509, 2000.
25. Kraly FS, Kim YM, Dunham LM, and Tribuzio RA. Drinking after intragastric NaCl without increase in systemic plasma osmolality in rats. Am J Physiol Regul Integr Comp Physiol 269: R1085-R1092, 1995.
26. Leenen FH, Ruzicka M, and Huang BS. The brain and salt-sensitive hypertension. Curr Hypertens Rep 4: 129-135, 2002.
27. Lohmeier TE, Lohmeier JR, Haque A, and Hildebrandt DA. Barore-flexes prevent neurally induced sodium retention in angiotensin hypertension. Am J Physiol Regul Integr Comp Physiol 279: R1437-R1448, 2000.
28. Matsuguchi H and Schmid PG. Pressor response to vasopressin and impaired baroreflex function in DOC-salt hypertension. Am J Physiol Heart Circ Physiol 242: H44-H49, 1982.
29. Mitchell J, Ling WD, and Bohr DF. Deoxycorticosterone acetate hypertension in the sheep. J Hypertens 2: 473-478, 1984.
30. Morita H, Matsuda T, Tanaka K, and Hosomi H. Role of hepatic receptors in controlling body fluid homeostasis. Jpn J Physiol 45: 355-368, 1995.
31. Morita H, Yamashita Y, Nishida Y, Tokuda M, Hatase O, and Hosomi H. Fos induction in rat brain neurons after stimulation of the hepatoportal Na-sensitive mechanism. Am J Physiol Regul Integr Comp Physiol 272: R913-R923, 1997.
32. O'Donaughy TL and Brooks VL. Deoxycorticosterone acetate-salt rats: hypertension and sympathoexcitation driven by increased NaCl levels. Hypertension 47: 680-685, 2006.
33. O'Donaughy TL, Qi Y, and Brooks VL. Central action of increased osmolality to support blood pressure in deoxycorticosterone acetate (DOCA)-salt rats. Hypertensionl 48: 658-663, 2006.
34. Okada H, Suzuki H, Kanno Y, and Saruta T. Effect of nonpeptide vasopressin receptor antagonists on developing, and established DOCA-salt hypertension in rats. Clin Exp Hypertens 17: 469-483, 1995.
35. Ouchi Y, Share L, Crofton JT, Iitake K, and Brooks DP. Sex difference in pressor responsiveness to vasopressin and baroreflex function in DOC-salt hypertensive rats. J Hypertension 6: 381-387, 1988.
36. Parati G. Blood pressure variability: its measurement and significance in hypertension. J Hypertens Suppl 23: S19-S25, 2005.
37. Schenk J and McNeill JH. The pathogenesis of DOCA-salt hypertension. J Pharmacol Toxicol Methods 27: 161-170, 1992.
38. Schiffrin EL. The many targets of aldosterone. Hypertension 43: 938-940, 2004.
39. Scott EM, Greenwood JP, Gilbey SG, Stoker JB, and Mary DA. Water ingestion increases sympathetic vasoconstrictor discharge in normal human subjects. Clin Sci (Lond) 100: 335-342, 2001.
40. Share L and Crofton JT. Contribution of vasopressin to hypertension. Hypertension 4, Suppl III: III-85-III-92, 1982.
41. Simon G. Experimental evidence for blood pressure-independent vascular effects of high sodium diet. Am J Hypertens 16: 1074-1078, 2003.
42. Stowasser M. New perspectives on the role of aldosterone excess in cardiovascular disease. Clin Exp Pharmacol Physiol 28: 783-791, 2001.
43. Stricker EM and Hoffmann ML. Inhibition of vasopressin secretion when dehydrated rats drink water. Am J Physiol Regul Integr Comp Physiol 289: R1238-R1243, 2005.
44. Stricker EM, Huang W, and Sved AF. Early osmoregulatory signals in the control of water intake and neurohypophyseal hormone secretion. Physiol Behav 76: 415-421, 2002.
45. Tajima Y, Ichikawa S, Sakamaki T, Matsuo H, Aizawa F, Kogure M, Yagi S, and Murata K. Body fluid distribution in the maintenance of DOCA-salt hypertension in rats. Am J Physiol Heart Circ Physiol 244: H695-H700, 1983.
46. Takata Y, Yamashita Y, Takishita S, and Fujishima M. Vasopressin and sympathetic nervous functions both contribute to development and maintenance of hypertension in DOCA-salt rats. Clin Exp Hyp Theory Prac A10: 203-227, 1988.
47. Takeda K, Nakamura Y, Hayashi J, Kawasaki S, Nakata T, Oguro M, Sasaki S, and Nakagawa M. Effects of salt and DOCA on hypothalamic and baroreflex control of blood pressure. Clin Exp Hypertens A 10, Suppl 1: 289-299, 1988.
48. Takeda K, Nakamura Y, Oguro M, Kawasaki S, Hayashi J, Tanabe S, Nakata T, Lee LC, Sasaki S, and Nakagawa M. Central attenuation of baroreflex precedes the development of hypertension in DOCA-salt-treated rats. Am J Hypertens 1: 23S-25S, 1988.
49. Thrasher TN. Effects of chronic baroreceptor unloading on blood pressure in the dog. Am J Physiol Regul Integr Comp Physiol 288: R863-R871, 2005.
50. Titze J, Bauer K, Schafflhuber M, Dietsch P, Lang R, Schwind KH, Luft FC, Eckardt KU, and Hilgers KF. Internal sodium balance in DOCA-salt rats: a body composition study. Am J Physiol Renal Physiol 289: F793-F802, 2005.
51. + balance, volume, and blood pressure homeostasis in intact and ovariectomized deoxycorticosterone-acetate salt rats. Hypertension 47: 1101-1107, 2006.
52. Toney GM, Chen QH, Cato MJ, and Stocker SD. Central osmotic regulation of sympathetic nerve activity. Acta Physiol Scand 177: 43-55, 2003.
53. Trinder D, Phillips PA, Risvanis J, Stephenson JM, and Johnston CI. Regulation of vasopressin receptors in deoxycorticosterone acetate-salt hypertension. Hypertension 20: 569-574, 1992.
54. Tsuji H, Larson MG, Venditti FJ Jr, Manders ES, Evans JC, Feldman CL, and Levy D. Impact of reduced heart rate variability on risk for cardiac events: the Framingham Heart Study. Circulation 94: 2850-2855, 1996.
55. Vollmer RR. Effects of dietary sodium on sympathetic nervous system control of cardiovascular function. J Auton Pharmacol 4: 133-144, 1984.
56. Wang DS, Xie HH, Shen FM, Cai GJ, and Su DF. Blood pressure variability, cardiac baroreflex sensitivity and organ damage in experimentally hypertensive rats. Clin Exp Pharmacol Physiol 32: 545-552, 2005.
57. Wang H, Huang BS, and Leenen FH. Brain sodium channels and ouabainlike compounds mediate central aldosterone-induced hypertension. Am J Physiol Heart Circ Physiol 285: H2516-H2523, 2003.
58. Wang W. Chronic administration of aldosterone depresses baroreceptor reflex function in the dog. Hypertension 24: 571-575, 1994.
59. Wangensteen R, Sainz J, Rodriguez-Gomez I, Moreno JM, Osuna A, and Vargas F. Chronic blockade of neuronal nitric oxide synthase does not affect long-term control of blood pressure in normal, saline-drinking or deoxycorticosterone- treated rats. Exp Physiol 88: 243-250, 2003.
60. Yamamoto J, Yamane Y, Umeda Y, Yoshioka T, Nakai M, and Ikeda M. Cardiovascular hemodynamics and vasopressin blockade in DOCA-salt hypertensive rats. Hypertension 6: 397-407, 1984.